Trade Group Efforts, Timing Bring AER System Concerns To Fore
This article was originally published in The Tan Sheet
Executive Summary
Congressional and industry cooperation over a broad dietary supplement/OTC drug adverse event reporting system is the result of long-term lobbying combined with recent momentum spurred by widespread safety concerns